Buteyko Based Remedial Breathing Therapy With Children With Asthma

Asthma Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02140086
• Other study ID #: RBT_03
• Secondary ID: RBT_03
• Status: Completed
• Phase: N/A
• First received: May 14, 2014
• Last updated: March 1, 2016
• Start date: January 2014
• Est. completion date: November 2014

Study information

• Verified date: March 2016
• Source: ARCIM Institute Academic Research in Complementary and Integrative Medicine
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: November 2014
• Est. primary completion date: November 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 6 Years to 15 Years

Eligibility

Inclusion Criteria:

• signed informed consent of the parents

• age 6- 15 years

• information and consent of the consulting doctor

• levels of asthma therapy 1-3

Exclusion Criteria:

• participation in another study

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Asthma

Intervention

Behavioral:
• Buteyko based Remedial Breathing Therapy
Buteyko based remedial Breathing Therapy after Dr. Buteyko

Locations

Country	Name	City	State
Germany	Filderklinik	Filderstadt	Baden-Württemberg

Sponsors (1)

Lead Sponsor	Collaborator
ARCIM Institute Academic Research in Complementary and Integrative Medicine

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up		asthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	Asthma Control Questionnaire (ACQ)	Scores of the ACQ (Asthma Control Questionnaire)	parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	Paediatric Asthma Quality of Life Questionnaire (PAQLQ)	Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)	parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	ARCIM Questionnaire (AFB)	Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)	parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	Peak Flow		parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	NO-measurement nasal and oral		parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	Buteyko-Questionnaire		parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	parameters of spirometry		parameters are measured before and after intervention as well as 3- and 6- month follow up	No
Secondary	Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ)		parameters are measured before and after intervention as well as 3- and 6- month follow up	No